Deaminase, adenosine(CAS: 9026-93-1)

Deaminase, adenosine (CAS: 9026-93-1) falls under the GHS classification as a biologically active substance. It is subject to stringent REACH regulations in the EU, which require detailed safety data sheets and registration of substances above a certain threshold. FDA and EPA regulations also apply, particularly for its use in pharmaceuticals and research. Compliance with these regulations is crucial for its safe handling and use.

Alternatives to Deaminase, adenosine (CAS: 9026-93-1) include other adenosine derivatives and enzymes with similar functionalities. Common substitutes include adenosine triphosphate (ATP) and other adenosine-based analogs. While these alternatives may have different reactivities and efficiencies, they offer flexibility in synthetic routes for researchers and chemists.

The market for Deaminase, adenosine (CAS: 9026-93-1) is growing due to its applications in drug discovery and development, particularly in cardiovascular and neurological research. Research trends are focusing on its use as a therapeutic agent and as a tool for studying adenosine receptor mechanisms. Demand is expected to rise as more applications are discovered.

Waste containing Deaminase, adenosine (CAS: 9026-93-1) should be collected in appropriate, leak-proof containers and stored under refrigeration to maintain stability. Proper waste disposal should adhere to local regulations, which may include incineration or professional waste disposal services. Environmental protection measures, such as minimizing exposure to water and air, are essential to prevent contamination.